The Effect of Three Prosthesis Designs in Total Knee Arthroplasty

NCT ID: NCT03059927

Last Updated: 2017-04-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

216 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare three prosthesis designs to compare three prosthesis designs for total knee arthroplasty and determine the best option for patients in need of a knee replacement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Total knee arthroplasty (TKA) is a cost beneficial surgery shown to improve pain, function and quality of life in patients with osteoarthritis. In 2015, 6093 patients received primary TKA in Norway. Despite the procedure´s general success, 20% of patients report persistent postoperative pain and/or dissatisfaction with the surgical outcome. Efforts to further improve the procedure have raised considerable debate regarding the role and management of the posterior cruciate ligament (PCL). Prostheses for TKA have evolved into designs that either preserve or sacrifice the PCL. In patients with a functional PCL, the decision of which design is selected depends largely on the favor and training of the surgeon. To further improve TKA patient outcomes, a better understanding of the role of these differing PCL treatments is needed. Thus, the aim of this study is to determine whether patients' perceived outcome, implant stability and clinical outcome differ between 3 TKA implant designs (2 PCL-sacrificing and 1 PCL-retaining). We will conduct a 3-arm randomized controlled prospective trial with 5-year follow-up. This study will have impact on clinical practice by addressing the lack of evidence supporting use of these different types of implants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gonarthrosis; Primary Degenerative Joint Disease of Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Knee arthroplasty, Cruciate retaining

Total knee replacement with preserved posterior cruciate ligament and a cruciate retaining insert.

Group Type ACTIVE_COMPARATOR

Knee arthroplasty, Cruciate retaining

Intervention Type PROCEDURE

Legion total knee arthroplasty implant component, Smith \& Nephew, Cruciate Retaining design

Knee arthroplasty, Anterior stabilized

Total knee replacement with sacrificed posterior cruciate ligament and an anterior stabilized insert.

Group Type ACTIVE_COMPARATOR

Knee arthroplasty, Anterior stabilized

Intervention Type PROCEDURE

Legion total knee arthroplasty implant component, Smith \& Nephew, Anterior Stabilized design

Knee arthroplasty, Posterior stabilized

Total knee replacement with sacrificed posterior cruciate ligament and a posterior stabilized design.

Group Type ACTIVE_COMPARATOR

Knee arthroplasty, Posterior stabilized

Intervention Type PROCEDURE

Legion total knee arthroplasty implant component, Smith \& Nephew, Posterior Stabilized design

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Knee arthroplasty, Cruciate retaining

Legion total knee arthroplasty implant component, Smith \& Nephew, Cruciate Retaining design

Intervention Type PROCEDURE

Knee arthroplasty, Anterior stabilized

Legion total knee arthroplasty implant component, Smith \& Nephew, Anterior Stabilized design

Intervention Type PROCEDURE

Knee arthroplasty, Posterior stabilized

Legion total knee arthroplasty implant component, Smith \& Nephew, Posterior Stabilized design

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary osteoarthritis
* Non-fixed or fixed varus or valgus deformity less than 15º measured on preoperative standing hip-knee-ankle (HKA) radiographs
* Intact PCL (assessed preoperatively and verified during surgery)
* Age 45 - 75 years (only patients 45 - 70 years will be included in the kinematic RSA)
* Body mass index ≤ 35 kg/m2
* ASA (American Society of Anaesthesiologists) score I or II
* Only patients with KOOS scores above 80 on the Symptoms, ADL (Activities of Daily Living) and Pain subscales will be included in the kinematic analysis

Exclusion Criteria

* Prior ACL (anterior cruciate ligament) surgery
* Impaired collateral ligaments
* Secondary osteoarthritis of the knee
* Previous osteotomy
* Rheumatic disease
* Flexion less than 90 degrees
* Flexion contracture over 10 degrees
* Peripheral neuropathy
* Malignancy
* Patients who do not speak Norwegian
Minimum Eligible Age

45 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Haugesund Rheumatism Hospital

OTHER

Sponsor Role collaborator

Lovisenberg Diakonale Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arild Aamodt, MD, PhD

Role: STUDY_DIRECTOR

Lovisenberg Diaconal Hospital, Oslo, Norway

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Haugesund Rheumatism Hospital

Haugesund, , Norway

Site Status NOT_YET_RECRUITING

Lovisenberg Diaconal Hospital

Oslo, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yasser Rehman, MD

Role: CONTACT

+4798477583

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Øystein Gøthesen, Md, PhD

Role: primary

988 08162

Arild Aamodt, MD, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LovisenbergOrto

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Kinematics of Contemporary Knee Arthroplasty
NCT02965690 ACTIVE_NOT_RECRUITING NA
The personalKNEE Trial
NCT06507046 RECRUITING NA